Ovarian hormones in premenopausal women: Variation by demographic, reproductive and menstrual cycle characteristics

Epidemiology

Volumn 13, Issue 6, 2002, Pages 675-684

  Windham, Gayle C ^a   Elkin, Eric ^a   Fenster, Laura ^a   Waller, Kirsten ^a   Anderson, Meredith ^a   Mitchell, Patrick R ^a   Lasley, Bill ^b   Swan, Shanna H ^a  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Estrogen; Hormones; Menstrual cycle; Progesterone; Women's health

Indexed keywords

ESTROGEN; PROGESTERONE;

ABORTION; ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; FOLLICULAR PHASE; HORMONE METABOLISM; HUMAN; LUTEAL PHASE; MENARCHE; MENSTRUAL CYCLE; OBESITY; OVARY FUNCTION; PREGNANCY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; ADOLESCENT; BREAST TUMOR; OVARY; PHYSIOLOGY; PREMENOPAUSE; SECRETION; URINE;

ADOLESCENT; ADULT; BREAST NEOPLASMS; DEMOGRAPHY; ESTROGENS; FEMALE; HUMANS; MENSTRUAL CYCLE; OVARY; PREMENOPAUSE; PROGESTERONE;

EID: 0036832373     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200211000-00012     Document Type: Article

References (38)

1. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
2. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progesterones, normal breast cell proliferation and breast cancer risk. Epidmiol Rev 1993:17-35.
3. Rosenberg C, Pasternack BS, Shore RE, Koenig KL, Toniolo PG. Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 1994;140:581-525.
4. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;1:48-65.
5. Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size and smoking. Am J Epidemiol 2001;153:1-10.
6. Risch HA, Marrett LD, Jain M, Howe GR. Difference in risk factors for epithelial ovarian cancer by histologic type: results of a case-control study. Am J Epidemiol 1996;144:363-372.
7. Sowers MR, Galuska DA. Epidemiology of bone mass in premenopausal women. Epidemiol Rev 1993;15:374-398.
8. Cooper GS, Sandler DP. Long-term effects of reproductive-age menstrual cycle patterns on peri- and postmenopausal fracture risk. Am J Epidemiol 1997;145:804-809.
9. Collins P. Vascular aspects of oestrogen. Maturitas 1996;23:217-226.
10. Baird DD, Weinberg CR, Zhou H, et al. Preimplantation urinary hormone profiles and the probability of conception in healthy women. Fertil Steril 1999;71:40-47.
11. Kolstad HA, Bonde JP, Hjollund NH, et al. Menstrual cycle pattern and fertility: a prospective follow-up study of pregnancy and early embryonal loss in 295 couples who were planning their first pregnancy. Fertil Steril 1999;71:490-496.
12. Harlow SD, Esphross SA. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev 1995;17:265-286.
13. Munro CJ, Stabenfeldt GH, Cragun JR, Addiego LA, Overstreet JW, Lasley BL. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem 1991;37:838-844.
14. Lasley BL, Shideler SE. Methods for evaluating reproductive health of women. In: Gold EB, Lasley BL, Schenker M, eds. Occupational Medicine: State of the Art Reviews: Reproductive Hazards. Philadelphia: Hanley and Belfus, 1994;423-433.
15. Gold EB, Eskenazi B, Lasley BL, et al. Correlates of progesterone metabolite levels in women (Abstract). Am J Epidemiol 1998;147: S56.
16. Westhoff C, Gentile G, Lee J, Zacur H, Helbig D. Predictors of ovarian steroid secretion in reproductive-age women. Am J Epidemiol 1996;144:381-388.
17. Windham GC, Elkin EP, Swan SH, Waller KO, Fenster L. Cigarette smoking and effects on menstrual function. Obstet Gynecol 1999;93:59-65.
18. Waller K, Swan SH, Windham GC, Fenster L, Elkin EP, Lasley BL. Use of urine biomarkers to evaluate menstrual function in healthy premenopausal women. Am J Epidemiol 1998;147:1071-1080.
19. Kassam A, Overstreet JW, Snow-Harter C, De Souza MJ, Gold EB, Lasley BL. Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm. Environ Health Perspect 1996;104:408-413.
20. Baird DD, Weinberg CR, Wilcox AJ, McConnaughey DR, Musey PI. Using the ratio of urinary estrogen and progesterone metabolites to estimate day of ovulation. Stat Med 1990;10:255-266.
21. Harlow SD, Zeger SL. An application of longitudinal methods to the analysis of menstrual diary data. J Clin Epidemiol 1991;44:1015-1025.
22. Martinez-Schenell B, Wilcox LS, Peterson HB, Jamison PM, Hughes JM. Evaluating the effects of tubal sterilization on menstrual function: selected issues in data analysis. Stat Med 1993;12:355-363.
23. Zeger S, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
24. Laird N, Ware J. Random effects models for longitudinal data. Biometrics 1982;38:963-974.
25. Harlow SD, Baird DD, Weinberg CR, Wilcox AJ. Urinary oestrogen patterns in long follicular phases. Hum Reprod 2000;1:11-16.
26. Landgren B-M, Unden A-L, Diczfalusy E. Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol (Copenh) 1980;94:89-98.
27. DeSouza MJ, Miller BE, Loucks AB, et al. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab 1998;83:4220-4232.
28. Moore JW, Key TJA, Wang DY, Bulbrook RD, Hayward JL, Takatani O. Blood concentrations of estradiol and sex hormone-binding globulin in relation to age at menarche in premenopausal British and Japanese women. Breast Cancer Res Treat 1991;18(suppl 1):S47-S50.
29. Apter D, Reinila M, Vihko R. Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 1989;44:783-787.
30. MacMahon B, Trichopoulos D, Brown J, et al. Age at menarche, urine estrogens and breast cancer risk. Int J Cancer 1982;30:427-431.
31. Bernstein L, Pike MC, Ross RK, Henderson BE. Age at menarche and estrogen concentrations of adult women. Cancer Causes Control 1991;2:221-225.
32. Dorgan JF, Reichman ME, Judd JT, et al. Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev 1995;4:381-386.
33. Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 1985;74:741-745.
34. Ecochard R, Marret H, Barbato M, Bodhringer H. Gonadotropin and body mass index: high FSH levels in lean, normally cycling women. Obstet Gynecol 2000;96:8-12.
35. Nagata C, Kaneda N, Kabuto M, Shimizu H. Factors associated with serum levels of estradiol and sex hormone-binding globulin among premenopausal Japanese women. Environ Health Perspect 1997;105:994-997.
36. Key TJA, Chen J, Wang DY, Pike MC, Boreham J. Sex hormones in women in rural China and in Britain. Br J Cancer 1990;62:631-636.
37. Aldercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E. Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 1994;86:1076-1082.
38. Whelan EA, Sandler DP, Root DL, Smith KR, Weinberg CR. Menstrual cycle patterns and risk of breast cancer. Am J Epidemiol 1994;140:1081-1090.